rising toad boats
Biotech

Why other Big Pharmas could follow Lilly into psychedelics

Industry experts told Fierce that Eli Lilly's $2.8 billion acquisition of AtaiBeckley should give the psychedelics space added momentum.
Will Maddox , Darren Incorvaia Jul 20, 2026 4:00am
Panther Rare Pharmacy

De-risking rare disease launches: precision beats scale

Brought to you by PANTHERx® Rare Pharmacy
Bristol Myers Squibb booth at AACR 2026

BMS, Nvidia aim for ‘most powerful AI factory in life sciences’

Jul 20, 2026 10:30am
BIO San Diego 2026 Executive Interviews

BIO San Diego 2026 Event Interviews

Brought to you by Questex
scribe papyrus papers feather pen jot write archive

Scribe aims for $96M IPO to fund lipid-lowering genetic meds

Jul 20, 2026 9:48am
Knee arthritis osteoarthritis

Kolon’s cell-based gene therapy fails ph.3 osteoarthritis test

Jul 20, 2026 9:25am
More News

Geopolitics ‘chills’ British biotech IPO plans, despite VC boost

Jul 20, 2026 7:45am

Latigo preps IPO to fund non-opioid rival to Vertex’s Journax

Jul 19, 2026 2:07pm

BlossomHill eyes IPO to grow taller in crowded cancer fields

Jul 17, 2026 12:08pm

Jasper merges with Kira, while Tavneos rival sent to Mirador

Jul 17, 2026 9:54am